Belinostat (Beleodaq)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Belinostat (Beleodaq), covering 2014-10-13 to 2025-09-16. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Combination of Belinostat and SGI-110 (Guadecitabine) or ASTX727 for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma [Phase 2]